Vitamin D3 The Alternative to previous therapy of glaucoma

VitaminD3+ Highdosage = good alternatve to the previous therapy of glaucoma+many others ophthalm.+general diseases like MS+Allergy; Prophylaxis cancer, stroke, heart attack, high blood pressure + cold

---

eBook release, Kindle-Amazon: English:ASIN B07D VTPY C9 (2018), in German ASIN B01E2S57KS. Many 5-star-reviews. 11.4.17 Publication of the printed book, 3rd edition, EPUBLI-Verlag Berlin, ISBN 9783 7450 505 407-1. 24x17 cm! 112 pages. Printbook in English: ISBN9783746752198. Available: my office, book trade, Amazon + directly from the publisher: s. Link to my homepage. My therapy is of great importance in G l a u c o m with high-dose D3 with a target of 100-150 ng / ml in the blood. Drug therapy + operations are eliminated. D3 is not toxic; only use: faster growth of hair + nails. D3, high dose, acts on many diseases e.g. Scotoma, cataract, AMD. As a contact lens expert, I published 2 books: Title "Contact Lenses, New Vision, Experience Yourself." Several scientific publications, last 2015: L adherence + complications from Kl in the right eye D3 improves tear film qualitatively, quantitatively, epithelial fragility + endothelium of the cornea. Safety during wear, especially in "permanent wear" + in orthokeratology (= removal of defective eyes with special class) .D3 is also effective in general medicine, in MS (Coimbra Kp.32): In my own case, healing of a colon Vesical-F istel: Specialists advised on the Op. (Item 6) .Improvement in depression, allergies, susceptibility to infections, hypertension, eczema, gait disturbances, general fatigue, etc. D3 for children (Kp.9) Another 16 new indications for D3 like Pulmonary hypertension (bp.6) K rebs prophylaxis is effective following the recommendations in section 8. Better compatibility with D3: chemo- + rays Therapy + Operations. In cancer, heart attacks, strokes mostly D3 deficiency. Treatment of atherosclerosis with MK 7 in vitamin K2 (bp.23) for the first time. New: Vit.-D3-Pope Holick: 3-D3 pathways (bp.34), GcMAF immunotherapy + Yamamoto D3 / Nagalase, primary + secondary D3 resistance (Kp.33). s. Homepage